Carregant...
Model-based optimization of G-CSF treatment during cytotoxic chemotherapy
PURPOSE: Although G-CSF is widely used to prevent or ameliorate leukopenia during cytotoxic chemotherapies, its optimal use is still under debate and depends on many therapy parameters such as dosing and timing of cytotoxic drugs and G-CSF, G-CSF pharmaceuticals used and individual risk factors of p...
Guardat en:
| Publicat a: | J Cancer Res Clin Oncol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Berlin Heidelberg
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5794835/ https://ncbi.nlm.nih.gov/pubmed/29103159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-017-2540-1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|